[go: up one dir, main page]

GB201301368D0 - Syringe - Google Patents

Syringe

Info

Publication number
GB201301368D0
GB201301368D0 GBGB1301368.5A GB201301368A GB201301368D0 GB 201301368 D0 GB201301368 D0 GB 201301368D0 GB 201301368 A GB201301368 A GB 201301368A GB 201301368 D0 GB201301368 D0 GB 201301368D0
Authority
GB
United Kingdom
Prior art keywords
syringe
plunger
stopper
outlet
contact surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1301368.5A
Other versions
GB2500092A (en
GB2500092B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47790686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB201301368(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2012101677A external-priority patent/AU2012101677B4/en
Priority claimed from DE201320000688 external-priority patent/DE202013000688U1/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of GB201301368D0 publication Critical patent/GB201301368D0/en
Publication of GB2500092A publication Critical patent/GB2500092A/en
Application granted granted Critical
Publication of GB2500092B publication Critical patent/GB2500092B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M5/31513Piston constructions to improve sealing or sliding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3129Syringe barrels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20Gaseous substances, e.g. vapours
    • A61L2/206Ethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20Gaseous substances, e.g. vapours
    • A61L2/208Hydrogen peroxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20Targets to be treated
    • A61L2202/24Medical instruments, e.g. endoscopes, catheters, sharps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M2005/3103Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A61M2005/3104Caps for syringes without needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3129Syringe barrels
    • A61M5/3137Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
    • A61M2005/3139Finger grips not integrally formed with the syringe barrel, e.g. using adapter with finger grips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501Means for blocking or restricting the movement of the rod or piston
    • A61M2005/31508Means for blocking or restricting the movement of the rod or piston provided on the piston-rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501Means for blocking or restricting the movement of the rod or piston
    • A61M5/31505Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A pre-filled syringe 1, the syringe 1 comprising a glass body 2, a stopper 10 and a plunger 4, the body comprising an outlet 12 at an outlet end 14 and the stopper 10 being arranged within the body 2 such that a front surface of the stopper 10 and the body 2 define a variable volume chamber 18 from which a fluid can be expelled through the outlet 12. The plunger 4 comprising a plunger contact surface 22 at a first end and a rod 26 extending between the plunger contact surface 22 and a rear portion 25, the plunger contact surface 22 arranged to contact the stopper 10 such, that the plunger 4 can be used to force the stopper 10 towards the outlet end 14 of the body 2, reducing the volume of the variable volume chamber 18. Characterised in that the fluid is an ophthalmic solution which comprises a VEGF antagonist. The syringe 1 has a nominal maximum fill volume between about 0.5ml and about 1ml. The syringe 1 is filled a dosage volume of between about 0.5ml and about 1ml. The syringe barrel 2 comprises less than about 500µg silicon oil. The VEGF antagonist solution comprises no more than 2 particles ¥50µm in diameter per ml.
GB1301368.5A 2012-07-03 2013-01-25 Syringe Active GB2500092B (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
EP12174860 2012-07-03
EP12189649 2012-10-23
AU2012101677A AU2012101677B4 (en) 2012-07-03 2012-11-16 Device
DE202012011016U DE202012011016U1 (en) 2012-07-03 2012-11-16 Aflibercept syringe
AU2012101678A AU2012101678B4 (en) 2012-07-03 2012-11-16 Use of device
DE202012011259U DE202012011259U1 (en) 2012-07-03 2012-11-23 Bevacizumab syringe
DE202012011260U DE202012011260U1 (en) 2012-07-03 2012-11-23 Ranibizumab Injection
EP12195360 2012-12-03
DE201320000688 DE202013000688U1 (en) 2012-07-03 2013-01-23 Glass syringe
AU2013100071A AU2013100071C4 (en) 2012-07-03 2013-01-23 Device
AU2013100070A AU2013100070B4 (en) 2012-07-03 2013-01-23 Use of device

Publications (3)

Publication Number Publication Date
GB201301368D0 true GB201301368D0 (en) 2013-03-13
GB2500092A GB2500092A (en) 2013-09-11
GB2500092B GB2500092B (en) 2014-02-12

Family

ID=47790686

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1301368.5A Active GB2500092B (en) 2012-07-03 2013-01-25 Syringe

Country Status (2)

Country Link
AU (5) AU2013100070B4 (en)
GB (1) GB2500092B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10780228B2 (en) 2012-05-07 2020-09-22 Medline Industries, Inc. Prefilled container systems
JOP20200175A1 (en) * 2012-07-03 2017-06-16 Novartis Ag Syringe
RU2702748C2 (en) * 2014-05-12 2019-10-11 Формикон Аг Pre-filled plastic syringe containing vegf antagonist
EP4556023A3 (en) 2015-11-18 2025-10-15 Formycon AG Pre-filled pharmaceutical package comprising a liquid formulation of a vegf-antagonist
US11654046B2 (en) 2015-11-18 2023-05-23 Sio2 Medical Products, Inc. Pharmaceutical package for ophthalmic formulations
US20170349313A1 (en) * 2016-06-01 2017-12-07 Centurion Medical Products Corporation Methods for manufacturing non-glass prefilled syringes
US20200237997A1 (en) * 2017-05-24 2020-07-30 Formycon Ag Sterilizable pre-filled pharmaceutical packages comprising a liquid formulation of a vegf-antagonist
CA3151375A1 (en) * 2019-08-01 2021-02-04 Kushal Garima Ophthalmic composition of bevacizumab
WO2021110910A2 (en) * 2019-12-05 2021-06-10 F. Hoffmann-La Roche Ag Syringe and tightness testing method
WO2022117556A1 (en) * 2020-12-01 2022-06-09 Boehringer Ingelheim International Gmbh Administration device for in particular intravitreal administration of a fluid
AU2023333370A1 (en) * 2022-08-30 2025-01-16 Amgen Inc. System and method of limiting subvisible particles in a syringe

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6243938B1 (en) * 1998-03-17 2001-06-12 Becton, Dickinson And Company Low silicone plastic prefillable syringe
US20030171320A1 (en) * 2001-11-09 2003-09-11 Guyer David R. Methods for treating ocular neovascular diseases
US20050043220A1 (en) * 2002-11-08 2005-02-24 Guyer David R. Methods and compositions for treating macular degeneration
PL1660057T3 (en) * 2003-08-27 2012-10-31 Ophthotech Corp Combination therapy for the treatment of ocular neovascular disorders
US20080027113A1 (en) * 2003-09-23 2008-01-31 Zeldis Jerome B Methods of Using and Compositions Comprising Immunomodulatory Compounds for Treatment and Management of Macular Degeneration
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
EP2311433A3 (en) * 2004-10-21 2011-08-10 Genentech, Inc. Method for treating intraocular neovascular diseases
CA2621047A1 (en) * 2005-02-02 2006-08-24 Regeneron Pharmaceuticals, Inc. Method of treating eye injury with local administration of a vegf inhibitor
EP1888150A1 (en) * 2005-05-31 2008-02-20 Baxter International Inc. Polypropylene hollow barrel with sliding coated rubber piston
CA2622573A1 (en) * 2005-09-16 2007-03-29 (Osi) Eyetech, Inc. Ophthalmic syringe
US20070071756A1 (en) * 2005-09-26 2007-03-29 Peyman Gholam A Delivery of an agent to ameliorate inflammation
US8168584B2 (en) * 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
AU2012202859C1 (en) * 2006-06-16 2025-08-07 Regeneron Pharmaceuticals, Inc. VEGF antagonist formulations suitable for intravitreal administration
SI2944306T1 (en) * 2006-06-16 2021-04-30 Regeneron Pharmaceuticals, Inc. Vegf antagonist formulations suitable for intravitreal administration
US20080070855A1 (en) * 2006-09-20 2008-03-20 James Pitzer Gills Treatment with anti-VEGF agents to prevent postoperative inflammation and angiogenesis in normal and diseased eyes
CN101868251B (en) * 2007-08-06 2012-10-10 千寿制药株式会社 Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
RU2550258C2 (en) * 2008-11-03 2015-05-10 Молекьюлар Партнерс Аг Binding proteins inhibiting vegf-a receptor interaction
CN102231994B (en) * 2008-12-03 2014-04-23 电气化学工业株式会社 Syringe
EP3165606A1 (en) * 2009-05-01 2017-05-10 Ophthotech Corporation Methods for treating or preventing ophthalmological diseases
CN102458471A (en) * 2009-05-28 2012-05-16 葛兰素集团有限公司 Combinations of TNFα antagonists and VEGF antagonists for use in the treatment or prevention of eye diseases
JP5212849B2 (en) * 2010-01-14 2013-06-19 株式会社三和化学研究所 Pharmaceutical for prevention or treatment of diseases associated with intraocular neovascularization and / or increased intraocular vascular permeability
CN201578690U (en) * 2010-01-21 2010-09-15 王建友 Syringe
US9408746B2 (en) * 2010-03-31 2016-08-09 Ocuject, Llc Device and method for intraocular drug delivery
US20130012918A1 (en) * 2011-07-07 2013-01-10 Gary Foster Steady grip ophthalmic surgical syringe and method

Also Published As

Publication number Publication date
AU2013100146A4 (en) 2013-03-28
AU2013100146B4 (en) 2013-04-18
AU2013100145A4 (en) 2013-03-28
GB2500092A (en) 2013-09-11
AU2013100147A4 (en) 2013-03-28
AU2013100070B4 (en) 2013-04-04
GB2500092B (en) 2014-02-12
AU2013100145B4 (en) 2013-05-02
AU2013100071B4 (en) 2013-03-28
AU2013100071A4 (en) 2013-03-07
AU2013100147B4 (en) 2013-04-18
AU2013100070A4 (en) 2013-03-07
AU2013100071C4 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
NZ702980A (en) Syringe
GB201301368D0 (en) Syringe
PH12014502675B1 (en) Syringe
MX2015008051A (en) Syringe pump system.
NZ618131A (en) A limiter for a dispensing device
NZ708682A (en) Dosator apparatus for filling a capsule with dry powder
EP4371592A3 (en) Variable single dose medicament delivery device
JP2017522983A5 (en)
IN2014KN02883A (en)
WO2011022611A3 (en) Syringe assembly with inverse delivery
MX340391B (en) Medicament delivery devices for administration of a medicament within a prefilled syringe.
WO2013079652A3 (en) Drug filled delivery assembly
WO2016100202A3 (en) Safety syringe and methods for administration of a medicament dose by subject weight
WO2015178592A3 (en) Fixed quantity discharge device for liquid container
HK1198246A1 (en) Reservoir or medicated module for a drug delivery system and method of and assembly for filling the same
JP2013533785A5 (en)
EP3511049A3 (en) Systems and methods for infusion of fluids using stored potential energy and a variable flow resistor
WO2016150900A3 (en) Injection device
WO2017045959A3 (en) Drug delivery device
WO2013092418A3 (en) A bubble entrapment device with variable volume
MX2015007521A (en) Syringe devices, components of syringe devices, and methods of forming components and syringe devices.
EP2489377A3 (en) Integrated syringe device with self-capping connector
EP2684815A3 (en) Unit dose system
MX2017003667A (en) Pre-filled syringe for ophthalmic application.
CN105621336A (en) Funnel capable of exhausting air conveniently

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1188404

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1188404

Country of ref document: HK

S72Z Claim or counterclaim for revocation before the court (sect. 72 patents act1977)

Free format text: CLAIM LODGED; CLAIM FOR REVOCATION LODGED AT THE PATENTS COURT ON 23 MARCH 2022 (HP-2022-000008)

S72Z Claim or counterclaim for revocation before the court (sect. 72 patents act1977)

Free format text: CLAIM LODGED; CLAIM FOR REVOCATION LODGED AT THE PATENTS COURT ON 7 JUNE 2022 (HP-2022-000015)

S72Z Claim or counterclaim for revocation before the court (sect. 72 patents act1977)

Free format text: CLAIM FOR REVOCATION LODGED AT THE PATENTS COURT ON 23 MARCH 2022 (HP-2022-000008) AND 7 JUNE 2022 (HP-2022-000015). PATENT REVOKED BY THE CONSENT ORDER OF HIGH COURT DATED 10 AUGUST 2023.

S75Z Amendment of patent in infringement or revocation proceedings before the court (sect. 75/patents act 1977)

Free format text: APPLICATION DISMISSED; CLAIM FOR REVOCATION LODGED AT THE PATENTS COURT ON 23 MARCH 2022 (HP-2022-000008) AND 7 JUNE 2022 (HP-2022-000015). IN A CONSENT ORDER OF THE HIGH COURT DATED 10 AUGUST 2023, THE PATENT WAS REVOKED AND THE AMENDMENTS UNDER SECTION 75 FILED ON 3 MAY 2023 WERE DISMISSED.